Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EB-5 Life Sciences, L.P. is a specialized investment fund and financing entity that provides capital to biotechnology and life sciences companies through the U.S. EB-5 Immigrant Investor Program. The partnership acts as a lender to biopharmaceutical firms, most notably providing multi-million dollar loan facilities to Ocugen, Inc. to support the clinical development, manufacturing, and commercialization of gene therapies and vaccines. By facilitating foreign investment into high-impact healthcare projects, EB-5 Life Sciences helps create jobs in the United States while offering investors a pathway to permanent residency. The fund's capital is typically utilized for R&D, clinical trials, and the construction of GMP manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EB-5 Life Sciences.